CH50 and C3 component of complement in Hansen's disease

Area of Science:

• Immunology
• Infectious Diseases
• Clinical Chemistry

Background:

• Complement system plays a role in immune response.
• Previous studies reported varied complement levels in leprosy patients.
• Leprosy exhibits a spectrum of clinical and immunological manifestations.

Purpose of the Study:

• To investigate complement component levels (CH50 and C3) in lepromatous leprosy patients.
• To compare complement values between leprosy patients and healthy controls.
• To explore factors contributing to discrepancies in reported complement levels in leprosy.

Main Methods:

• Sera from 233 lepromatous leprosy patients and 30 healthy controls were analyzed.
• Complement levels were assessed using CH50 and C3 assays.
• Statistical analysis was performed to compare complement values between groups.

Main Results:

• No statistically significant difference in CH50 and C3 levels was observed between lepromatous leprosy patients and healthy controls.
• A borderline statistical difference in C3 was noted in a small subgroup of borderline patients, requiring further investigation.
• A notable proportion of sera exhibited either low or high complement values, indicative of complement activation or inflammatory processes.

Conclusions:

• Overall complement levels (CH50, C3) do not significantly differ in lepromatous leprosy.
• Disease stage and drug administration are likely key factors influencing complement variability in leprosy.
• Further research is needed to clarify the role of complement in specific leprosy forms and its response to treatment.